Literature DB >> 14499118

Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity.

Toshikatsu Hanada1, Hiroki Yoshida, Seiya Kato, Kentaro Tanaka, Kohsuke Masutani, Jun Tsukada, Yoshio Nomura, Hiromitsu Mimata, Masato Kubo, Akihiko Yoshimura.   

Abstract

Suppressor of cytokine signaling-1 (SOCS1/JAB) negatively regulates not only the cytokine-signaling pathway but also lipopolysaccharide (LPS)-induced macrophage activation. We found that SOCS1-deficient dendritic cells (DCs) were also hyperresponsive to interferon-gamma and interleukin-4. To define the role of SOCS1-deficient DCs in vivo, we generated mice in which the SOCS1 expression was restored in T and B cells on a SOCS1(-/-) background. In these mice, DCs were accumulated in the thymus and spleen and produced high levels of BAFF/BLyS and APRIL, resulting in the aberrant expansion of B cells and autoreactive antibody production. SOCS1-deficient DCs efficiently stimulated B cell proliferation in vitro and autoantibody production in vivo. These results indicate that SOCS1 plays an essential role in the normal DC functions and suppression of systemic autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14499118     DOI: 10.1016/s1074-7613(03)00240-1

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  78 in total

1.  Requirement of myeloid cell-specific Fas expression for prevention of systemic autoimmunity in mice.

Authors:  Carla M Cuda; Hemant Agrawal; Alexander V Misharin; G Kenneth Haines; Jack Hutcheson; Evan Weber; Joseph A Schoenfeldt; Chandra Mohan; Richard M Pope; Harris Perlman
Journal:  Arthritis Rheum       Date:  2012-03

2.  Differential regulation of Toll-like receptor signalling in spleen and Peyer's patch dendritic cells.

Authors:  Julie M Davies; John MacSharry; Fergus Shanahan
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

3.  Enhanced induction of HIV-specific cytotoxic T lymphocytes by dendritic cell-targeted delivery of SOCS-1 siRNA.

Authors:  Sandesh Subramanya; Myriam Armant; Janelle R Salkowitz; Alice M Nyakeriga; Viraga Haridas; Maroof Hasan; Anju Bansal; Paul A Goepfert; Katherine K Wynn; Kristin Ladell; David A Price; Manjunath N; June Kan-Mitchell; Premlata Shankar
Journal:  Mol Ther       Date:  2010-07-20       Impact factor: 11.454

Review 4.  Suppressors of cytokine signaling in health and disease.

Authors:  Jane C Tan; Ralph Rabkin
Journal:  Pediatr Nephrol       Date:  2005-02-19       Impact factor: 3.714

Review 5.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

6.  SOCS1 restricts dendritic cells' ability to break self tolerance and induce antitumor immunity by regulating IL-12 production and signaling.

Authors:  Kevin Evel-Kabler; Xiao-Tong Song; Melissa Aldrich; Xue F Huang; Si-Yi Chen
Journal:  J Clin Invest       Date:  2005-12-15       Impact factor: 14.808

7.  Deficiency of Bim in dendritic cells contributes to overactivation of lymphocytes and autoimmunity.

Authors:  Min Chen; Li Huang; Jin Wang
Journal:  Blood       Date:  2007-01-16       Impact factor: 22.113

8.  Dendritic cell-dependent inhibition of B cell proliferation requires CD22.

Authors:  Lorna Santos; Kevin E Draves; Mark Boton; Prabhjit K Grewal; Jamey D Marth; Edward A Clark
Journal:  J Immunol       Date:  2008-04-01       Impact factor: 5.422

9.  Combining MPDL3280A with adoptive cell immunotherapy exerts better antitumor effects against cervical cancer.

Authors:  Yi Zheng; Yicheng Yang; Shu Wu; Yongqiang Zhu; Xiaolong Tang; Xiaopeng Liu
Journal:  Bioengineered       Date:  2016-10-18       Impact factor: 3.269

10.  Suppression of microRNA-155 attenuates neuropathic pain by regulating SOCS1 signalling pathway.

Authors:  Yi Tan; Jun Yang; Kai Xiang; Qindong Tan; Qulian Guo
Journal:  Neurochem Res       Date:  2014-12-09       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.